Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,345 | -291,955 | -227,877 | -150,697 | -72,865 |
| Depreciation Amortization | 1,341 | 2,811 | 1,451 | 551 | 277 |
| Accounts receivable | -6,639 | -9,670 | -3,890 | 0 | N/A |
| Accounts payable and accrued liabilities | -4,217 | 7,657 | -2,496 | 4,479 | 3,935 |
| Other Working Capital | -8,601 | 7,939 | 6,352 | 11,470 | 6,782 |
| Other Operating Activity | 36,208 | 110,748 | 89,599 | 52,243 | 25,829 |
| Operating Cash Flow | $-6,253 | $-172,470 | $-136,861 | $-81,954 | $-36,042 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -431 | -286 | -132 | -124 |
| Purchase Of Investment | 0 | -79,729 | -79,728 | -79,513 | -79,728 |
| Sale Of Investment | 0 | 114,724 | 88,096 | 43,650 | 25,779 |
| Purchase Sale Intangibles | N/A | -50,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -50,000 | 0 | 1 | 0 |
| Investing Cash Flow | $-40 | $-15,436 | $8,082 | $-35,994 | $-54,073 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50,000 | 0 | N/A | N/A |
| Common Stock Issued | 3,147 | 26,685 | 14,002 | 4,271 | 706 |
| Other Financing Activity | 0 | -1,575 | 0 | 0 | 0 |
| Financing Cash Flow | $3,147 | $75,110 | $14,002 | $4,271 | $706 |
| Beginning Cash Position | 86,015 | 198,811 | 198,811 | 198,811 | 198,811 |
| End Cash Position | 82,869 | 86,015 | 84,034 | 85,134 | 109,402 |
| Net Cash Flow | $-3,146 | $-112,796 | $-114,777 | $-113,677 | $-89,409 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,253 | -172,470 | -136,861 | -81,954 | -36,042 |
| Capital Expenditure | -40 | -431 | -286 | -132 | -124 |
| Free Cash Flow | -6,293 | -172,901 | -137,147 | -82,086 | -36,166 |